Enfusion, INC Form 4 insider transactions

Director Deirdre Somers reports acquisition and disposition of Enfusion, Inc. stock to cover tax obligations.

Director Michael Spellacy reported the acquisition of 13,470 restricted stock units (RSUs) in Enfusion, Inc. on June 13, 2024.

Director Jan Hauser acquired 13,470 shares of Enfusion, Inc. Class A Common Stock on June 13, 2024, through the vesting of restricted stock units.

Kathleen DeRose, a director at Enfusion, Inc., reported the acquisition of 13,470 shares of Class A Common Stock on June 13, 2024, through the vesting of restricted stock units.

Lawrence E. Leibowitz, a director of Enfusion, Inc., acquired 13,470 shares of Class A Common Stock on June 13, 2024, according to a Form 4 filing with the SEC.

Bronwen Bastone, Chief People Officer of Enfusion, Inc., sold 34,059 shares of Class A Common Stock on May 20, 2024, at a weighted average price of $9.55.

Oleg Movchan, CEO of Enfusion, Inc., reports the acquisition of Class A Common Stock and Restricted Stock Units (RSUs) through direct and indirect ownership.

Oleg Movchan, CEO of Enfusion, Inc., reports acquisition and disposal of Class A Common Stock, including shares acquired through vested options and shares withheld for tax obligations.

Enfusion's Chief Operating Officer, Neal Pawar, reports the acquisition of restricted stock units.

Valeria Gutowski, Chief Accounting Officer of Enfusion, Inc., reports transactions involving Class A Common Stock, including acquisition of restricted stock units and shares, as well as shares withheld for tax obligations.

Enfusion's CFO, Bradley Herring, reports acquisition and disposal of Class A Common Stock, including vested shares and shares withheld for tax obligations.

Matthew Campobasso, General Counsel of Enfusion, Inc., reports acquisition and disposal of Class A Common Stock related to restricted stock units and tax obligations.

Bronwen Bastone, Chief People Officer of Enfusion, Inc., reports transactions involving Class A Common Stock, including the acquisition of restricted stock units and shares, as well as shares withheld for tax obligations.

Matthew Campobasso, General Counsel of Enfusion, Inc., sold 108 shares of Class A Common Stock on February 29, 2024, to cover tax withholding obligations.

Valeria Gutowski, Chief Accounting Officer of Enfusion, Inc., reported selling 27 shares of Class A Common Stock on February 29, 2024, to cover tax withholding obligations.